(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEW YORK CANCER & BLOOD SPECIALISTS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NEW YORK CANCER & BLOOD SPECIALISTS

ST13

US500000087688894

Class

42, 44

Filing

87688894

Registration

5517911

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

12/20/2024

Trademark type

Combined

Nice classes

42, 44

Filing date

11/17/2017

Registration date

07/17/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/20/2024

Last transaction

12/20/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

2011-07-00

First use in commerce

2011-07-00

Drawing code

3

Owner type

03

Owner location

East Setauket, NY, US

Examiner

JOINER, KATINA

Current location

Historical data usage

Mark description

The mark consists of a magenta ribbon wrapped around a blue figure of the state of New York on the left side of the words "NEW YORK" over a line and the words "CANCER & BLOOD" which is over a line and the words "SPECIALISTS". The wording and the lines are in the color grey.

Holders and representatives

Holders

North Shore Hematology Oncology Associates, PC

Representatives

Stephen R. Barrese, Esq. DILWORTH & BARRESE, LLP

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical researchconducting clinical trials for others

Class 44

Medical services; healthcare; healthcare servicesdiagnosis and treatment of cancer; hematology and oncology consulting services; healthcare and medical serviceschemotherapy and radiation therapydiagnostic imagingcirculating tumor cell (ctc) testingprostate vaccination therapy; hematology services; medical counseling; medical imaging services

Publications

History of USPTO decisions and trademark events.

21 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/20/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/20/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/20/2024

E815

TEAS SECTION 8 & 15 RECEIVED

07/22/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/17/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

07/17/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/01/2018

PUBO

PUBLISHED FOR OPPOSITION

05/01/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/11/2018

ALIE

ASSIGNED TO LIE

03/26/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/17/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/17/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/16/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/16/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/12/2018

GNRT

NON-FINAL ACTION E-MAILED

03/12/2018

CNRT

NON-FINAL ACTION WRITTEN

03/12/2018

DOCK

ASSIGNED TO EXAMINER

03/02/2018

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/01/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/30/2017

NWAP

NEW APPLICATION ENTERED

11/21/2017

Continuous trademark protection

Get notified about every new filing that threatens NEW YORK CANCER & BLOOD SPECIALISTS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.